Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics

M Lopez-Siles, SH Duncan, LJ Garcia-Gil… - The ISME …, 2017 - academic.oup.com
There is an increasing interest in Faecalibacterium prausnitzii, one of the most abundant
bacterial species found in the gut, given its potentially important role in promoting gut health …

Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease

HC Mirsepasi-Lauridsen, BA Vallance… - Clinical microbiology …, 2019 - Am Soc Microbiol
Gut bacteria play a key role in initiating and maintaining the inflammatory process in the gut
tissues of inflammatory bowel disease (IBD) patients, by supplying antigens or other …

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

K Machiels, M Joossens, J Sabino, V De Preter, I Arijs… - Gut, 2014 - gut.bmj.com
Objective Bacteria play an important role in the onset and perpetuation of intestinal
inflammation in inflammatory bowel disease (IBD). Unlike in Crohn's disease (CD), in which …

[HTML][HTML] Role of gut microbiota in infectious and inflammatory diseases

MF Maciel-Fiuza, GC Muller, DMS Campos… - Frontiers in …, 2023 - frontiersin.org
Thousands of microorganisms compose the human gut microbiota, fighting pathogens in
infectious diseases and inhibiting or inducing inflammation in different immunological …

[HTML][HTML] Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis

L Zhu, LZ Xu, S Zhao, ZF Shen, H Shen… - Applied Microbiology and …, 2020 - Springer
Baicalin is reported as an effective drug for ulcerative colitis (UC). However, its effect on gut
microbiota and short-chain fatty acids (SCFAs) remains unknown. In this study, we …

The relationship between gut microbiota and weight gain in humans

E Angelakis, F Armougom, M Million… - Future microbiology, 2012 - Future Medicine
The human gut microbiota is a metabolic organ that is determined by a dynamic process of
selection and competition. Age, dietary habits and geographical origin of people have an …

Increased short-and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis

KO Gradel, HL Nielsen, HC Schønheyder, T Ejlertsen… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Various commensal enteric and potentially pathogenic bacteria
may be involved in the pathogenesis of inflammatory bowel diseases (IBD). We compared …

Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease

C Prantera, H Lochs, M Grimaldi, S Danese… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: Bacteria might be involved in the development and persistence of
inflammation in patients with Crohn's disease (CD), and antibiotics could be used in therapy …

[HTML][HTML] Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences

P Gabarre, C Loens, Y Tamzali, B Barrou… - American Journal of …, 2022 - Elsevier
Our understanding of the involvement of the gut microbiota (GM) in human health has
expanded exponentially over the last few decades, particularly in the fields of metabolism …

The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review

R Lucas López, MJ Grande Burgos, A Gálvez… - Apmis, 2017 - Wiley Online Library
Inflammatory bowel disease (IBD) includes a spectrum of diseases from ulcerative colitis
(UC) to Crohn's disease (CD). Many studies have addressed the changes in the microbiota …